Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.
Press releases published on September 3, 2025
GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
Live webcast presentation with CEO, Dr. Marc Hertz, on September 9th at 3:00 PM ET LA JOLLA, CA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of …
M4Markets Aligns with Centroid to Deliver Top-Grade Liquidity to Clients
GlobeNewswire
·
September 3, 2025
Victoria, Seychelles, Sept. 03, 2025 (GLOBE NEWSWIRE) -- M4Markets, a multi-regulated global broker known for its competitive spreads and fast execution, has announced a strategic partnership with Centroid Solutions. Through this collaboration, M4Markets …
Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS)
GlobeNewswire
·
September 3, 2025
ISELIN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it will present at …
BitMEX and TradingView Announce Trading Campaign, Offering 100,000 USDT in Rewards and More
GlobeNewswire
·
September 3, 2025
VICTORIA, Seychelles, Sept. 03, 2025 (GLOBE NEWSWIRE) -- BitMEX, the safest crypto derivatives exchange, today announced a new campaign rewarding users that place spot, futures and perpetual swap trades on BitMEX via TradingView. The campaign, which began …
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
GlobeNewswire
·
September 3, 2025
Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation FDA acceptance starts the review process and sets timing for potentially the first new FDA-approved …
Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
GlobeNewswire
·
September 3, 2025
SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that IP Australia (the Australian Patent …
Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025
GlobeNewswire
·
September 3, 2025
LAKE FOREST, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) announced that members of its management team will host investor meetings at two investor conferences in New York City during …
Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …
Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025
GlobeNewswire
·
September 3, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- SOUTH SAN FRANCISCO, Calif., September 2, 2025 — Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its …
Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference
GlobeNewswire
·
September 3, 2025
BOTHELL, Wash., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the H.C. Wainwright 27th Annual Global Investment …
LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer
GlobeNewswire
·
September 3, 2025
-- Company Relocates Corporate Headquarters to Boca Raton -- Boca Raton, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing a …
Lyell Immunopharma Announces the Initiation of a Phase 3 Head-to-Head CAR T-Cell Therapy Clinical Trial in Aggressive Large B-Cell Lymphoma and Formation of Expert Steering Committee
GlobeNewswire
·
September 3, 2025
PiNACLE - H2H will evaluate rondecabtagene autoleucel (ronde-cel) versus investigator’s choice of approved CD19 CAR T-cell therapies in patients with aggressive large B-cell lymphoma receiving treatment in the second line (2L) setting Ronde-cel is Lyell’s …
NevGold Starts Drilling And Identifies Additional Stibiconite (Oxide Antimony Mineral) Outcrops at Gold-Antimony Limo Butte Project
GlobeNewswire
·
September 3, 2025
Vancouver, British Columbia, Sept. 03, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQB:NAUFF) (Frankfurt:5E50) is pleased to announce the commencement of the 2025 drill program at the oxide gold-antimony (“Antimony”, “ …
BridgeBio to Host Autosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar on Wednesday, September 10th at 8:00 am ET
GlobeNewswire
·
September 3, 2025
PALO ALTO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company will host an investor webinar on …
Avicanna Subsidiary Completes Export of CBD Dominant Cannabis Flower into Switzerland
GlobeNewswire
·
September 3, 2025
This marks the first export of organic certified flower for SMGH, 20th international market for Aureus branded products and 23rd market for all Avicanna products TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: …
OnEquity Secures Mauritius Investment Dealer License, Reinforcing Global Regulatory Standing
GlobeNewswire
·
September 3, 2025
PORT LOUIS, Mauritius, Sept. 03, 2025 (GLOBE NEWSWIRE) -- OnEquity announced today that its subsidiary, OnEquity (MU) Ltd., has been granted an Investment Dealer (Full Service Dealer, excluding Underwriting) license by the Financial Services Commission ( …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 3, 2025
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted nine newly-hired employees stock options to purchase an …
XORTX Initiates IND Preparation for XORLO™ in Gout Program
GlobeNewswire
·
September 3, 2025
CALGARY, Alberta, Sept. 03, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and …
Koryx Copper Drills Widest Historic Continuous High-Grade Zone
GlobeNewswire
·
September 3, 2025
110M @ 0.70% CU (TRUE WIDTHS UNKNOWN) EPL 3140 LICENSE RENEWAL SUBMISSION OF MINING LICENSE APPLICATION AT THE HAIB COPPER PROJECT, SOUTHERN NAMIBIA Highlights Drillhole HM90 intersects 110m @ 0.70% Cu (0 to 110m), incl. 36m @ 1.42% Cu (28 to 64m) within a …
Dundee Precious Metals Completes Acquisition of Adriatic Metals and Confirms Name Change and ASX Listing
GlobeNewswire
·
September 3, 2025
TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX:DPM) (“DPM”) is pleased to announce the completion of its previously announced acquisition (the “Acquisition”) of the entire issued, and to be issued, ordinary share capital of …